Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
BioMatrix Specialty Infusion Pharmacy General Information
BioMatrix provides commercial specialty infusion services nationwide with a focus on high-touch patient management for chronic and complex conditions. The company has demonstrated significant growth through organic expansion and acquisitions. It recently acquired MyLyfe Health to further strengthen its position in ambulatory/home infusion services. In early 2023, it divested its oral specialty business to focus exclusively on home-based specialty infusions. No clinical trial results are reported as it operates as a service provider rather than a drug developer.
Contact Information
Primary Industry
Non-Academic Healthcare
Corporate Office
Plantation/Fort Lauderdale*, Florida
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Not specifically listed; works closely with manufacturers, payors, providers for patient access programs.
BioMatrix Specialty Infusion Pharmacy Funding
No funding data available
To view BioMatrix Specialty Infusion Pharmacy's complete valuation and funding history, request access »